Status:
COMPLETED
Pilot Study of Sex-matched vs. Sex-mismatched Red Blood Cell Transfusion
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Blood Transfusion
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Blood transfusion is common for patients in hospital, especially for those in intensive care. Patients receive blood that is matched to them based on their blood group (A, B, AB, O), but not based on ...
Detailed Description
Blood transfusion is one of the most common procedures performed during hospitalization. Approximately 85 million red blood cell (RBC) units are transfused globally each year. RBC units are matched fo...
Eligibility Criteria
Inclusion
- Adults (age ≥18)
- Admitted to the intensive care unit
- Requiring a red blood cell transfusion
Exclusion
- Requiring a specific red blood cell unit or unit not readily available (e.g., phenotypically matched, rare blood, washed, complex red blood cell antibodies, etc.)
- Massively bleeding (i.e. ≥4 units of blood ordered, or Massive Hemorrhage Protocol initiated, or an urgent blood request made)
- Biological sex unknown
Key Trial Info
Start Date :
January 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04814264
Start Date
January 7 2022
End Date
February 28 2023
Last Update
March 16 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2
2
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6
3
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7
4
London Health Sciences Centre
London, Ontario, Canada, N6A 5W9